NHS Scottish National Blood Transfusion Service (SNBTS) Cell Therapy eSolution

Descriptions

The Common Services Agency (more commonly known as NHS National Services Scotland or NSS) (“NSS”), acting through its directorate the Scottish National Blood Transfusion Service (“SNBTS”), is undertaking the procurement of two electronic eSolutions that will allow onboarding of novel cell therapy projects from research centres, facilitating project development and eventual translation into a Good Manufacturing Practice (GMP) environment. The two eSolution systems between them will encompass five Phases across an entire product life cycle of an Advanced Therapeutic from development through to clinical use. System 1 will include onboarding of research documentation, development, and initial stages of technology transfer (Phase 1 and Phase 2). System 2 will include the final stages of technology transfer into GMP validation, batch manufacture and have report producing capabilities to allow for quality approval then release/certification for patient use (Phase 3, 4 and 5). The solutions must be provided using a Software as a Service (SaaS) model. Further information can be found within the Invitation to Tender (ITT) and appendices located on PCS-Tender.